Robert Matthew Lutz
First SEC filing: Feb. 14, 2025 · Latest: Feb. 14, 2025
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 15, 2026 | SVRA | A | 70,000 | · | · | 70,000 Direct | · | Acquired | (price as of 2026-10-05) |
| July 15, 2026 | SVRA | A | 35,000 | · | · | 328,977 Direct | +11.91% | Acquired | (price as of 2026-10-05) |
| Dec. 14, 2025 | SVRA | F | 67,760 | $6.92 | $468,899 | 293,977 Direct | -18.73% | Disposed | -30.9% (price as of 2026-10-05) |
| Feb. 13, 2025 | SVRA | F | 38,263 | $2.83 | $108,284 | 361,737 Direct | -9.57% | Disposed | 68.9% (price as of 2026-10-05) |
| Dec. 12, 2024 | SVRA | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 12, 2024 | SVRA | A | 100,000 | · | · | 400,000 Direct | +33.33% | Acquired | (price as of 2026-10-05) |
| Dec. 14, 2023 | SVRA | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 14, 2023 | SVRA | A | 160,000 | · | · | 300,000 Direct | +114.29% | Acquired | (price as of 2026-10-05) |
| Feb. 24, 2023 | SVRA | A | 350,000 | · | · | 350,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 24, 2023 | SVRA | A | 140,000 | · | · | 140,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 11, 2022 | IBIO | A | 100,057 | · | · | 102,165 Direct | +4746.54% | Acquired | (price as of 2026-10-05) |
| Aug. 29, 2022 | IBIO | A | 400,000 | · | · | 400,000 Direct | · | Acquired | (price as of 2026-10-05) |
| March 10, 2022 | IBIO | S | 24,625 | $0.35 | $8,619 | 207,375 Direct | -10.61% | Disposed | -99.4% (price as of 2026-10-05) |
| Aug. 23, 2021 | IBIO | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-05) |
| March 4, 2021 | IBIO | A | 350,000 | · | · | 350,000 Direct | · | Acquired | (price as of 2026-10-05) |
| March 4, 2021 | IBIO | A | 232,000 | · | · | 232,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 15, 2026 | SVRA | Stock Option (Right to Buy) | Common Stock | $5.81 | July 15, 2036 | 70,000 | Acquired |
| Dec. 12, 2024 | SVRA | Stock Option (Right to Buy) | Common Stock | $3.35 | Dec. 12, 2034 | 300,000 | Acquired |
| Dec. 14, 2023 | SVRA | Stock Option (Right to Buy) | Common Stock | $4.45 | Dec. 14, 2033 | 40,000 | Acquired |
| Feb. 24, 2023 | SVRA | Stock Option (Right to Buy) | Common Stock | $2.53 | Feb. 24, 2033 | 350,000 | Acquired |
| Aug. 29, 2022 | IBIO | Stock Option (right to buy) [F1] | Common Stock | $0.28 | Aug. 28, 2032 | 400,000 | Acquired |
| Aug. 23, 2021 | IBIO | Stock Option (right to buy) [F1] | Common Stock | $1.26 | Aug. 22, 2031 | 500,000 | Acquired |
| March 4, 2021 | IBIO | Stock Option (right to buy) | Common Stock | $1.43 | March 4, 2031 | 350,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $471,000 | · | · | · | $176,625 | · | $18,000 | $2,278,125 |
| 2024 | $454,480 | $18,179 | · | $864,337 | $181,792 | · | $18,000 | $1,871,788 |
| 2023 | $387,341 | $143,405 | · | $874,534 | $174,800 | · | $18,000 | $2,664,280 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $425,000 | · | · | · | · | · | · | $1,157,922 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.